Hypera S.A. (BST:HM6A)

Germany flag Germany · Delayed Price · Currency is EUR
3.460
+0.040 (1.17%)
At close: Mar 18, 2026
Market Cap2.34B +16.4%
Revenue (ttm)1.19B +3.4%
Net Income184.84M -10.9%
EPS0.29 -10.2%
Shares Outn/a
PE Ratio12.63
Forward PE7.85
Dividend0.13 (3.71%)
Ex-Dividend DateMar 2, 2026
Volumen/a
Average Volume30
Open3.420
Previous Close3.420
Day's Range3.420 - 3.500
52-Week Range2.980 - 4.700
Betan/a
RSI43.97
Earnings DateMar 12, 2026

About Hypera

Hypera S.A. operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, pleased, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, Luna, moon, Lydian, macrodantin, MaxSulid, Milgamma, Mioflex – A, Nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, Softalm, Tacroz, Tinodin, Umma, an... [Read more]

Industry Pharmaceutical Preparations
Founded 1999
Employees 10,481
Stock Exchange Stuttgart Stock Exchange
Ticker Symbol HM6A
Full Company Profile